J. C. Jager

1.6k total citations
65 papers, 1.2k citations indexed

About

J. C. Jager is a scholar working on Economics and Econometrics, Epidemiology and General Health Professions. According to data from OpenAlex, J. C. Jager has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Economics and Econometrics, 20 papers in Epidemiology and 12 papers in General Health Professions. Recurrent topics in J. C. Jager's work include HIV/AIDS Impact and Responses (15 papers), HIV/AIDS Research and Interventions (10 papers) and Influenza Virus Research Studies (7 papers). J. C. Jager is often cited by papers focused on HIV/AIDS Impact and Responses (15 papers), HIV/AIDS Research and Interventions (10 papers) and Influenza Virus Research Studies (7 papers). J. C. Jager collaborates with scholars based in Netherlands, United States and Spain. J. C. Jager's co-authors include Maarten J. Postma, Marianne L.L. van Genugten, Marie‐Louise A. Heijnen, Wim J. van der Steen, André J.H.A. Ament, Silvia Evers, Jeroen N. Struijs, Geertrudis A.M. van den Bos, Mirjam Kretzschmar and Reiner Leidl and has published in prestigious journals such as Stroke, Journal of Ecology and Emerging infectious diseases.

In The Last Decade

J. C. Jager

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. C. Jager Netherlands 20 550 256 213 191 111 65 1.2k
Birgitte Freiesleben de Blasio Norway 22 408 0.7× 432 1.7× 82 0.4× 76 0.4× 104 0.9× 79 1.4k
Melvin A. Kohn United States 19 533 1.0× 518 2.0× 106 0.5× 100 0.5× 22 0.2× 39 2.0k
Patrick M. Tarwater United States 34 688 1.3× 1.2k 4.7× 65 0.3× 48 0.3× 97 0.9× 110 3.5k
Martyn Regan United Kingdom 22 260 0.5× 350 1.4× 76 0.4× 26 0.1× 14 0.1× 74 1.3k
J. Daniel Kelly United States 33 257 0.5× 973 3.8× 118 0.6× 51 0.3× 20 0.2× 185 3.5k
James Chin United States 16 326 0.6× 388 1.5× 164 0.8× 67 0.4× 26 0.2× 35 1.2k
Joseph McLaughlin United States 20 167 0.3× 230 0.9× 89 0.4× 16 0.1× 25 0.2× 59 1.4k
Li Deng United States 23 852 1.5× 529 2.1× 43 0.2× 24 0.1× 91 0.8× 86 1.7k

Countries citing papers authored by J. C. Jager

Since Specialization
Citations

This map shows the geographic impact of J. C. Jager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. C. Jager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. C. Jager more than expected).

Fields of papers citing papers by J. C. Jager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. C. Jager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. C. Jager. The network helps show where J. C. Jager may publish in the future.

Co-authorship network of co-authors of J. C. Jager

This figure shows the co-authorship network connecting the top 25 collaborators of J. C. Jager. A scholar is included among the top collaborators of J. C. Jager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. C. Jager. J. C. Jager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feenstra, Talitha, et al.. (2002). Cost effectiveness of guideline advice for children with asthma: A literature review. Pediatric Pulmonology. 34(6). 442–454. 14 indexed citations
2.
Postma, Maarten J., et al.. (2002). Pharmacoeconomics of Influenza Vaccination for Healthy Working Adults. Drugs. 62(7). 1013–1024. 41 indexed citations
3.
Postma, Maarten J., et al.. (2001). Pharmaco-economics of drug addiction: estimating the costs of hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection among injecting drug users in member States of the European Union*. University of Groningen research database (University of Groningen / Centre for Information Technology). 53(1). 6. 6 indexed citations
4.
Postma, Maarten J., et al.. (2000). Pharmaco-economic evaluation of universal HIV-screening of pregnant women; a cost-effectiveness analysis for Amsterdam.. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 144(16). 749–754. 2 indexed citations
5.
Postma, Maarten J., et al.. (2000). Screening for asymptomatic infection with Chlamydia trachomatis in pregnancy; favourable cost-effectiveness if prevalence is 3% or more.. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 144(49). 2350–2354. 3 indexed citations
6.
Downs, Angela M., Siem H. Heisterkamp, Lucilla Ravà, et al.. (2000). Back-calculation by birth cohort, incorporating age-specific disease progression, pre-AIDS mortality and change in European AIDS case definition. AIDS. 14(14). 2179–2189. 12 indexed citations
7.
Welte, R, Mirjam Kretzschmar, Reiner Leidl, et al.. (2000). Cost-Effectiveness of Screening Programs for Chlamydia trachomatis. Sexually Transmitted Diseases. 27(9). 518–529. 76 indexed citations
8.
Postma, Maarten J., et al.. (1999). Economic Evaluation of Influenza Vaccination. PharmacoEconomics. 16(Supplement 1). 33–40. 53 indexed citations
9.
Baltussen, Rob, M Sprenger, Maarten J. Postma, et al.. (1998). Estimating influenza-related hospitalization in the Netherlands. Epidemiology and Infection. 121(1). 129–138. 31 indexed citations
10.
Postma, Maarten J., et al.. (1998). Disease-staging for modelling current and future health-care impact of disease: illustrations for Diabetes Mellitus and AIDS. Health Policy. 43(1). 45–54. 6 indexed citations
11.
Dijkgraaf, Marcel G. W., et al.. (1996). Lifetime hospitalization profiles for symptomatic, HIV-infected persons. Health Policy. 35(1). 13–32. 8 indexed citations
12.
13.
Dijkgraaf, Marcel G. W., et al.. (1994). Trends in hospital resource utilization by HIV-infected persons, January 1987–June 1990. Health Policy. 27(2). 175–191. 4 indexed citations
14.
Kretzschmar, Mirjam, et al.. (1994). The basic reproduction ratio R0 for a sexually transmitted disease in pair formation model with two types of pairs. Mathematical Biosciences. 124(2). 181–205. 27 indexed citations
15.
Postma, Maarten J., Reiner Leidl, Angela M. Downs, et al.. (1993). Economic impact of the AIDS epidemic in the European Community. AIDS. 7(4). 541–554. 18 indexed citations
16.
Heisterkamp, S. H., et al.. (1992). Short and medium term projections of the aids/hiv epidemic by a dynamic model with an application to the risk group of homo/bisexual men in amsterdam. Statistics in Medicine. 11(11). 1425–1441. 9 indexed citations
17.
Borleffs, Jan C.C., et al.. (1990). Hospital cost for patients with HIV infection in a University Hospital in The Netherlands. Health Policy. 16(1). 43–54. 12 indexed citations
18.
Jager, J. C., et al.. (1990). HIV infection dynamics and intervention experiments in linked risk groups. Statistics in Medicine. 9(7). 721–736. 11 indexed citations
19.
Jong‐Brink, Marijke de, et al.. (1985). Statistical analysis of frequencies and proportions of cytologically classified spermatogenic cells in the hermaphroditic snailLymnaea stagnalis.1. A study of diurnal variations. International Journal of Invertebrate Reproduction and Development. 8(3). 149–159. 2 indexed citations
20.
Jager, J. C., et al.. (1976). A quantitative description of heterotrophic growth in micro-organisms. Journal of Theoretical Biology. 57(1). 103–120. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birgitte Freiesleben de Blasio Breakdown of academic impact, for papers by Melvin A. Kohn Breakdown of academic impact, for papers by Patrick M. Tarwater Breakdown of academic impact, for papers by Martyn Regan Breakdown of academic impact, for papers by J. Daniel Kelly Breakdown of academic impact, for papers by James Chin Breakdown of academic impact, for papers by Joseph McLaughlin Breakdown of academic impact, for papers by Li Deng
Rankless by CCL
2026